Guided Therapeutics (GTHP) Gross Margin Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -136.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -324.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 311.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 56.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -164.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 124.00 |
| 10 | Guided Therapeutics | - | - | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -4,167.00 |
| Jun 30, 2025 | -1,248.00 |
| Dec 31, 2024 | -26,833.00 |
| Dec 31, 2023 | -29,000.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 648,000.00 |
| Mar 31, 2022 | -1,444.00 |
| Dec 31, 2021 | 17,310.00 |
| Sep 30, 2021 | -22,105.00 |
| Jun 30, 2021 | 1,250.00 |
| Dec 31, 2020 | 55,308.00 |
| Sep 30, 2020 | 27,835.00 |
| Dec 31, 2019 | 3,611.00 |
| Sep 30, 2019 | 8,947.00 |
| Dec 31, 2018 | -249,365.00 |
| Sep 30, 2018 | 170,000.00 |
| Jun 30, 2018 | 112,750.00 |
| Mar 31, 2018 | -10,833.00 |
| Dec 31, 2017 | -24,385.00 |
| Sep 30, 2017 | -20,303.00 |
| Jun 30, 2017 | 64,211.00 |
| Mar 31, 2017 | 39,223.00 |
| Dec 31, 2016 | 8,629.00 |
| Sep 30, 2016 | 7,913.00 |
| Dec 31, 2015 | 238,760.00 |
| Sep 30, 2015 | -159,827.00 |
| Jun 30, 2015 | -103,497.00 |
| Mar 31, 2015 | 4,308.00 |
| Dec 31, 2014 | -7,972.00 |
| Sep 30, 2014 | -8,307.00 |
| Jun 30, 2014 | -72,859.00 |
| Mar 31, 2014 | -46,203.00 |
| Jun 30, 2013 | -9,589.00 |